Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Endoscopic Suturing (ES) Registry

6. december 2021 opdateret af: American Gastroenterological Association

Prospective Registry for Trans-Orifice Endoscopic Suturing Applications

To determine patient outcomes (survival, additional endoscopic or surgical procedures) with an endoscopic suturing technique at predetermined intervals compared to historical controls when applicable.

To evaluate the efficacy, safety, and durability of trans-orifice endoscopic suturing therapy for revision of bariatric procedures as well as study the safety, efficacy, and durability of preventative fixation of GI endoprosthetics.

Studieoversigt

Status

Afsluttet

Betingelser

Detaljeret beskrivelse

To determine patient outcomes (survival, morbidity including hospitalization, additional re-interventions with radiologic, endoscopic or surgical procedures) with endoscopic suturing at predetermined intervals from the last endoscopic suturing procedure or at failure of the endoscopic suturing with conversion to another intervention such as surgery and compared to historical controls when applicable.

To evaluate the efficacy and safety of endoscopic suturing therapy in preventative fixation of stents and bariatric revision.

To collect data on the common use endoscopic suturing therapy in other indications.

This prospective clinical study is a real-world registry and not a randomized controlled trial. Given the conditions commonly treated with endoscopic suturing and the potential lack of equivalent expertise in open, laparoscopic, and trans-oral surgical procedures at all centers, randomization of participants is not possible nor ethical. In addition, there are clinical scenarios where endoscopic therapy with surgical sutures, tissue sealants, and/or endoprosthetics may be appropriate and open and laparoscopic surgical approaches inappropriate from an ethical viewpoint. Given the multitude of currently available minimally invasive approaches to repair, it would be unethical to expose and randomize patients who are suitable for more minimally invasive approaches to a more invasive and inherently more morbid approach.

This outcomes study is external to the subject receiving the medical device treatment. Subjects will receive the medical device treatment regardless of study participation and the surgery is not part of this research. Subjects will be consented prior to their procedure, to obtain basic follow-up information. If the subject provides informed consent to participate in the registry, then site staff will follow the participant's clinical data for the period of the registry. Site staff may also contact the subject(s) during their standard clinic visit or via the telephone and obtain information on: overall health, specific events related to any subsequent surgical, endoscopic, or radiologic interventions, and hospitalizations.

The clinical data will be collected during usual procedure follow-ups. This will include recording patient demographics, medications, testing results, comorbidities, body mass index, and reason for clinical care visit. If during the follow-up period, the subject undergoes additional clinically indicated procedures or hospitalizations for procedure related indications then the site will submit this information to the registry.

All procedures and device use will be performed as clinically indicated and as directed by the treating physician. All information requested as part of this registry will be obtained from clinical data obtained as part of study.

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

204

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Arkansas
      • Little Rock, Arkansas, Forenede Stater, 72211
        • University of Arkansas
    • Florida
      • Jacksonville, Florida, Forenede Stater, 32224
        • Mayo Clinic Jacksonville
      • Jacksonville, Florida, Forenede Stater, 32256
        • Borland Grover Clinic
    • Illinois
      • Evanston, Illinois, Forenede Stater, 60201
        • NorthShore University Healthsystem
    • Maryland
      • Baltimore, Maryland, Forenede Stater, 21224
        • Johns Hopkins Medical Institution
    • Missouri
      • Saint Louis, Missouri, Forenede Stater, 63110
        • Washington University
    • New York
      • Manhasset, New York, Forenede Stater, 11030
        • Northwell Health
      • New York, New York, Forenede Stater, 10021
        • New York Presbyterian Hospital
      • New York, New York, Forenede Stater, 10029
        • Mount Sinai Hospital
    • Pennsylvania
      • Hershey, Pennsylvania, Forenede Stater, 17033
        • Penn State Hershey Medical Center
    • Texas
      • Dallas, Texas, Forenede Stater, 75214
        • Methodist Dallas Medical Center

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

N/A

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Adults with a condition that can be treated with trans-orifice endoscopic surgery.

Beskrivelse

Inclusion Criteria:

  1. Selected to undergo trans-orifice suturing prior to study enrollment
  2. Age 18+ years
  3. Patient ASA classification I, II, III, including emergency cases
  4. Patient willing to provide informed consent, cooperate with post-operative recommendations and follow-up assessment

Exclusion Criteria:

  1. Patients who do not meet the clinical criteria for trans-orifice suturing
  2. Under age 18 years
  3. ASA classification IV
  4. Unable to provide informed consent
  5. Unable to participate in follow-up assessments
  6. Uncorrectable coagulopathy at the time of endoscopic suturing
  7. Any terminal disease that limits patient's survival to less than one year

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
no groups - observational study

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Dislocation of Stent - distance
Tidsramme: Change at 2 weeks, 30 days, 3 months
Change in the position measured using distance (centimeters).
Change at 2 weeks, 30 days, 3 months
Dislocation of Stent - location
Tidsramme: Change at 2 weeks, 30 days, 3 months
Change in the position measured using location. Location options: Bridging the GJ anastomosis, Confined to gastric lumen, Bridging the pylorus, Bridging Lower Esophageal Sphincter
Change at 2 weeks, 30 days, 3 months
Migration Rate of Stent - placement
Tidsramme: Change at 2 weeks, 30 days, 3 months
Distal from placement over time (yes or no)
Change at 2 weeks, 30 days, 3 months
Migration Rate of Stent - replaced
Tidsramme: Change at 2 weeks, 30 days, 3 months
Stent replaced or re-structured over time (yes or no)
Change at 2 weeks, 30 days, 3 months
Migration Rate of Stent - sutures
Tidsramme: Change at 2 weeks, 30 days, 3 months
Number of intact Sutures
Change at 2 weeks, 30 days, 3 months
Migration Rate of Stent - removal
Tidsramme: Change at 2 weeks, 30 days, 3 months
Days to removal and replacement
Change at 2 weeks, 30 days, 3 months
Excess Weight Loss
Tidsramme: Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
Changes in body weight measured in kilograms subsequent to the revisional procedure will be summarized using statistics both in percentage terms using the % excess weight lost and absolute terms.
Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
Total Weight Loss
Tidsramme: Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
Changes in body weight measured in kilograms subsequent to the revisional procedure will be summarized using statistics both in percentage terms using the % total weight loss and absolute terms.
Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Samarbejdspartnere

Efterforskere

  • Ledende efterforsker: Jennifer Maranki, MD, Penn State Milton S. Hershey School of Medicine

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

29. oktober 2018

Primær færdiggørelse (Faktiske)

30. november 2021

Studieafslutning (Faktiske)

30. november 2021

Datoer for studieregistrering

Først indsendt

3. november 2018

Først indsendt, der opfyldte QC-kriterier

13. december 2018

Først opslået (Faktiske)

14. december 2018

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

7. december 2021

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

6. december 2021

Sidst verificeret

1. december 2021

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • ES Registry 2-682-101

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

produkt fremstillet i og eksporteret fra U.S.A.

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Kirurgi

3
Abonner